Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
136
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Prostate Cancer Recurrent
Interventions
DRUG:
[18F]PSMA-1007
Sponsor
ABX advanced biochemical compounds GmbH